Germany
· Delayed Price · Currency is EUR Moderna Statistics
Total Valuation
Moderna has a market cap or net worth of EUR 8.40 billion. The enterprise value is 688.90 million.
| Market Cap | 8.40B |
| Enterprise Value | 688.90M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | -3.51% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 360.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.69 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.20 |
| EV / Sales | 0.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.18 |
Financial Position
The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.67 |
| Quick Ratio | 3.45 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.18 |
| Interest Coverage | -164.38 |
Financial Efficiency
Return on equity (ROE) is -28.77% and return on invested capital (ROIC) is -18.44%.
| Return on Equity (ROE) | -28.77% |
| Return on Assets (ROA) | -15.14% |
| Return on Invested Capital (ROIC) | -18.44% |
| Return on Capital Employed (ROCE) | -33.05% |
| Revenue Per Employee | 538,906 |
| Profits Per Employee | -593,029 |
| Employee Count | 5,800 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 37.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.08% in the last 52 weeks. The beta is 1.54, so Moderna's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | -77.08% |
| 50-Day Moving Average | 29.04 |
| 200-Day Moving Average | 51.66 |
| Relative Strength Index (RSI) | 31.37 |
| Average Volume (20 Days) | 1,169 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.39 |
Income Statement
In the last 12 months, Moderna had revenue of EUR 3.13 billion and -3.44 billion in losses. Loss per share was -8.96.
| Revenue | 3.13B |
| Gross Profit | -2.68B |
| Operating Income | -3.81B |
| Pretax Income | -3.48B |
| Net Income | -3.44B |
| EBITDA | -3.63B |
| EBIT | -3.81B |
| Loss Per Share | -8.96 |
Balance Sheet
The company has 6.79 billion in cash and 721.53 million in debt, giving a net cash position of 8.47 billion.
| Cash & Cash Equivalents | 6.79B |
| Total Debt | 721.53M |
| Net Cash | 8.47B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 10.53B |
| Book Value Per Share | 27.28 |
| Working Capital | 5.69B |
Cash Flow
In the last 12 months, operating cash flow was -2.90 billion and capital expenditures -1.02 billion, giving a free cash flow of -3.92 billion.
| Operating Cash Flow | -2.90B |
| Capital Expenditures | -1.02B |
| Free Cash Flow | -3.92B |
| FCF Per Share | n/a |
Margins
Gross margin is -85.63%, with operating and profit margins of -121.91% and -110.04%.
| Gross Margin | -85.63% |
| Operating Margin | -121.91% |
| Pretax Margin | -111.46% |
| Profit Margin | -110.04% |
| EBITDA Margin | -116.07% |
| EBIT Margin | -121.91% |
| FCF Margin | n/a |
Dividends & Yields
Moderna does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.52% |
| Shareholder Yield | -0.52% |
| Earnings Yield | -40.93% |
| FCF Yield | -46.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Moderna has an Altman Z-Score of 7.29.
| Altman Z-Score | 7.29 |
| Piotroski F-Score | n/a |